Skip to content

Drinking Habits of Glaucoma Patients and Age Matched Controls

Clinical Study to Evaluate the Drinking Habits of Glaucoma Patients and Age Matched Controls

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01503996
Enrollment
600
Registered
2012-01-04
Start date
2011-10-31
Completion date
2015-10-31
Last updated
2015-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dehydration, Glaucoma

Keywords

dehydration, risk factor, glaucoma, Controls

Brief summary

The purpose of this study is to examine if a chronic dehydration is a risk factor for the developement or progression of some forms of glaucoma.

Detailed description

Glaucoma patients who are hospitalized for diurnal intraocular pressure measurements and glaucoma assessment are asked about their drinking habits. Objective evaluation of hydration status is assessed with the Body Composition Monitor (Fresenius). Retinal Vessel Analysis and Laser Doppler Flowmetry are investigated in subgroups. The control group are also hospitalized patients who do not suffer from glaucoma.

Interventions

BEHAVIORALalter drinking habits

if dehydration is apparent, more fluid intake is recommended

Sponsors

Technische Universität Dresden
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* glaucoma patients * controls

Exclusion criteria

* psychiatric disease, * epilepsy, pregnancy, * nutritional disorder, * malfunction of blood clotting and wound healing, * pacemaker, * metallic stents

Design outcomes

Primary

MeasureTime frameDescription
Dehydration4 yearsThe composition of a patient's body, in particular a patient's water content are determined with bioimpedance spectroscopy (Body Composition Monitor, FRESENIUS)

Secondary

MeasureTime frameDescription
microvascular changes4 yearsTo investigate differences in retinal vessel diameters measured with the Retinal Vessel Analyzer (RVA, IMEDOS) in glaucoma patients and controls

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026